申请人:SK Corporation
公开号:US07078537B2
公开(公告)日:2006-07-18
The present invention relates to novel 1,2- or 1,3-diamine and amide compounds and pharmaceutically useful salts thereof and methods for treating central nervous system diseases. The present 1,2- or 1,3-diamine and amide compounds have high binding affinity to the sigma receptor.
本发明涉及新型的1,2-或1,3-二胺和酰胺化合物及其药用盐,以及治疗中枢神经系统疾病的方法。本发明中的1,2-或1,3-二胺和酰胺化合物具有与σ受体高结合亲和力。